OCULAR THERAPEUTIX, INC (OCUL) Selling and Marketing Expense USD 2013 - 2024

Historical data

Taxonomy & unit
us-gaap: USD
Description
The aggregate total amount of expenses directly related to the marketing or selling of products or services.
Summary
Ocular Therapeutix, Inc quarterly/annual Selling and Marketing Expense history and growth rate from 2013 to 2024.
  • Ocular Therapeutix, Inc Selling and Marketing Expense for the quarter ending March 31, 2024 was $10.2 M, a 6.02% decline year-over-year.
  • Ocular Therapeutix, Inc Selling and Marketing Expense for the twelve months ending March 31, 2024 was $39.9 M, a 4.31% decline year-over-year.
  • Ocular Therapeutix, Inc annual Selling and Marketing Expense for 2023 was $40.5 M, a 1.57% increase from 2022.
  • Ocular Therapeutix, Inc annual Selling and Marketing Expense for 2022 was $39.9 M, a 13.4% increase from 2021.
  • Ocular Therapeutix, Inc annual Selling and Marketing Expense for 2021 was $35.2 M, a 32.2% increase from 2020.
Selling and Marketing Expense, Trailing 12 Months (USD)
Selling and Marketing Expense, Quarterly (USD)
Selling and Marketing Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $39.9 M $10.2 M -$652 K -6.02% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-07
Q4 2023 $40.5 M $9.25 M -$1.29 M -12.2% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-11
Q3 2023 $41.8 M $9.32 M -$871 K -8.55% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-07
Q2 2023 $42.7 M $11.2 M +$1.01 M +9.99% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-07
Q1 2023 $41.7 M $10.8 M +$1.77 M +19.6% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-07
Q4 2022 $39.9 M $10.5 M +$1.4 M +15.3% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-11
Q3 2022 $38.5 M $10.2 M +$610 K +6.37% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-07
Q2 2022 $37.9 M $10.1 M +$1.75 M +20.8% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-07
Q1 2022 $36.2 M $9.06 M +$977 K +12.1% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-08
Q4 2021 $35.2 M $9.14 M +$2.33 M +34.2% Oct 1, 2021 Dec 31, 2021 10-K 2024-03-11
Q3 2021 $32.9 M $9.58 M +$3.06 M +46.9% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-07
Q2 2021 $29.8 M $8.39 M +$2.24 M +36.4% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-08
Q1 2021 $27.6 M $8.09 M +$956 K +13.4% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-09
Q4 2020 $26.6 M $6.81 M -$331 K -4.64% Oct 1, 2020 Dec 31, 2020 10-K 2023-03-06
Q3 2020 $26.9 M $6.52 M -$257 K -3.79% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-08
Q2 2020 $27.2 M $6.15 M -$1.07 M -14.8% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-09
Q1 2020 $28.3 M $7.13 M +$3.78 M +113% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-05
Q4 2019 $24.5 M $7.14 M +$4.85 M +212% Oct 1, 2019 Dec 31, 2019 10-K 2022-02-28
Q3 2019 $19.6 M $6.78 M +$5.71 M +535% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-05
Q2 2019 $13.9 M $7.23 M +$6.36 M +733% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-07
Q1 2019 $7.57 M $3.35 M +$2.63 M +367% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-08
Q4 2018 $4.94 M $2.29 M +$1.39 M +154% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-12
Q3 2018 $3.55 M $1.07 M -$2.17 M -67% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-12
Q2 2018 $5.73 M $867 K -$5.97 M -87.3% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-07
Q1 2018 $11.7 M $717 K -$5.31 M -88.1% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-10
Q4 2017 $17 M $903 K -$1.62 M -64.3% Oct 1, 2017 Dec 31, 2017 10-K 2020-03-12
Q3 2017 $18.6 M $3.24 M +$1.94 M +150% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-07
Q2 2017 $16.7 M $6.83 M +$5.34 M +358% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-07
Q1 2017 $11.3 M $6.03 M +$4.64 M +334% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-08
Q4 2016 $6.7 M $2.53 M +$1.38 M +121% Oct 1, 2016 Dec 31, 2016 10-K 2019-03-07
Q3 2016 $5.32 M $1.29 M +$496 K +62.2% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-07
Q2 2016 $4.82 M $1.49 M +$451 K +43.3% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-08
Q1 2016 $4.37 M $1.39 M +$519 K +59.7% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-05
Q4 2015 $3.85 M $1.14 M +$485 K +73.7% Oct 1, 2015 Dec 31, 2015 10-K 2018-03-08
Q3 2015 $3.37 M $798 K +$319 K +66.6% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-09
Q2 2015 $3.05 M $1.04 M +$506 K +94.6% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-09
Q1 2015 $2.54 M $870 K +$560 K +181% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-10
Q4 2014 $1.98 M $658 K Oct 1, 2014 Dec 31, 2014 10-K 2017-03-10
Q3 2014 $479 K +$331 K +224% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-10
Q2 2014 $535 K +$392 K +274% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-10
Q1 2014 $310 K Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-15
Q3 2013 $148 K Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-12
Q2 2013 $143 K Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-29
* An asterisk sign (*) next to the value indicates that the value is likely invalid.